L, Z., K, Z., H, Z., J, Z., Y, P., Z, W., . . . B, W. (2019). Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Dove Medical Press.
Style de citation Chicago (17e éd.)L, Zhang, Zhu K, Zeng H, Zhang J, Pu Y, Wang Z, Zhang T, et Wang B. Resveratrol Solid Lipid Nanoparticles to Trigger Credible Inhibition of Doxorubicin Cardiotoxicity. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)L, Zhang, et al. Resveratrol Solid Lipid Nanoparticles to Trigger Credible Inhibition of Doxorubicin Cardiotoxicity. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.